Organogenesis Holdings Inc 's ROA from the second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics

What is Organogenesis Holdings Inc 's ROA in the second quarter of 2026?
Organogenesis Holdings Inc recorded a cumulative net loss of $-94 million during 12 months ending in the second quarter of 2026, resulting in a negative return on assets (ROA) of -18.46%.

However, within the Healthcare sector 351 other companies had a higher return on assets. While return on assets, the total ranking has deteriorated compared to the first quarter of 2026 from 1400 to 2751.

What is ROA?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Assets ROA▼

None ▼

Return on Assets ROA▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Assets	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Total Assets Change	-11.86 %	11.25 %	30.07 %	23.31 %	11.91 %
Y / Y Net Income Change	-	-	595.09 %	18.93 %	-
Net Income (TTM) in million	-94	-10	25	-13	-15
Return On Assets (TTM)	-18.46 %	-1.86 %	4.87 %	-2.65 %	-3.31 %
ORGO's Total Ranking	# 2751	# 1400	# 2862	# 2908	# 3018
Total Assets (TTM) in million	406	520	599	510	461
Seq. Total Assets Change	-21.84 %	-13.15 %	17.44 %	10.56 %	-1.34 %
Seq. Net Income Change	-	-	197.99 %	-	-

ORGO's 5 Years Annual ROA >> Back to ORGO Management Effectiveness >> Compare ORGO ROA to its Competitors

Return On Assets Company Ranking
Within:	No.
Industry	# 126
Sector	# 352
Overall	# 3393

Return On Assets Statistics
High	Average	Low
25.5 %	-2.59 %	-26.92 %
(Dec 31 2021)		(Sep 30 2019)

Financial Statements
Organogenesis Holdings Inc 's Assets	$ 406 million	ORGO's Balance sheet
Organogenesis Holdings Inc 's Income	$ -96 million	Quarterly ORGO's Income Statement
ORGO's Income by Division		See ORGO's Income by Division

Annual Return On Assets	(Dec 31 2025) FY 2025	(Dec 31 2024) FY 2024	(Dec 31 2023) FY 2023	(Dec 31 2022) FY 2022	(Dec 31 2021) FY 2021
Y / Y Total Assets Change	30.07 %	6.08 %	2.91 %	1.7 %	40.78 %
Total Assets in million	599	460	434	422	415
Y / Y Net Income Change	-	-	-68.16 %	-83.63 %	428.73 %
Net Income in million	21	-1	5	16	95
Annual Return On Assets	3.43 %	-0.11 %	1.14 %	3.68 %	22.89 %

ORGO's 5 Years Annual ROA >> Back to ORGO Management Effectiveness >> Compare ORGO ROA to its Competitors

Comment on ORGO's ROA in the fiscal year ending 2025

In the fiscal year 2025 ROA improved to 3.43 % compared to prior year, due to annual net income growth of % to $20.56 million, while value of Organogenesis Holdings Inc 's overall assets grew just by 30.07 % to $598.73 million, compared to $598.73 a year before.

More Return On Assets Ratios
ORGO's' Return on Assets at Yahoo Finance
Major Pharmaceutical Preparations Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
ORGO's Roa Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for ORGO's Competitors
Subscribers only: Roa for Organogenesis Holdings Inc 's Suppliers
Subscribers only: Return On Assets for ORGO's Customers

You may also want to know
ORGO's Roi	ORGO's Inventory Turnover Ratio	ORGO's Growth Rates	ORGO's Dividend Comparisons
	ORGO's Profitability Ratios	ORGO's Asset Turnover Ratio	ORGO's Dividend Growth
ORGO's Roe	ORGO's Valuation Ratios	ORGO's Financial Strength Ratios	ORGO's Dividend Payout Ratio

Companies with similar Return On Assets at Jun 30 2026, within Healthcare Sector

ROA

Date modified: 2026-09-26T07:31:38+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.